ABSTRACT
Potentiates insulin secretion when stimulated by other agents;
Delays gastric emptying;
May decrease food intake.
A stable analogue or non-peptide GLP-1 receptor agonist may be
developed, allowing this to be used in conjunction with other agents.
Some imidazoline derivatives stimulate glucose-independent insulin
